View Author
patient mutation disease lrrk 2 parkinsonism neurology 2019ser journal supranuclear palsy tauopathie study idiopathic pd parkinson symptom research pathology idiopathic onset protein dementia supranuclear disorder brain model neuro fibrillary tangles palsy lrrk 2-associated pd treatment microtubule centre musculu cause scale university frequency phenotype carrier tauopathy atrophy european syndrome tangle family kinase neuro department estimate state gsk -3 activity penetrance neuron table motor ó 2009 frontotemporal trial stage frontotemporal dementia qsbb series consortium author group lrrk 2 mutations series hospital hyperphosphorylation institute tau pathology tau hyperphosphorylation 10 years fibrillary fference diagnosis 297–309 science criteria alzheimer compilation london degeneration
2 Most Recent Publications
|
Tauopathies with parkinsonism: Clinical spectrum, neuropathologic basis, biological markers, and treatment options
(Article)
Ludolph, A.C. Kassubek, J. Hoglinger, G. Jamrozik, Z. Jellinger, K.A. Kazantsev, A. Kretzschmar, H. Lang, A.E. Litvan, I. Lucas, J.J. McGeer, P.L. Melquist, S. Landwehrmeyer, B.G. Oertel, W. Otto, M. Paviour, D. Reum, T. Saint-Raymond, A. Steele, J.C. Tolnay, M. Tumani, H. Swieten, J.C. van Vanier, M.T. Mandelkow, E. Vonsattel, J.P. Wagner, S. Wszolek, Z.K. Burn, D.J. Caparros-Lefebvre, D. Frey, K.A. Yebenes, J.G. de Gasser, T. Heutink, P. |
2009-03-01
|
|
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
(Article)
Healy, D.G. Falchi, M. Ferreira, J.J. Tolosa, E. Kay, D.M. Klein, C. Williams, D.R. Marras, C. Lang, A.E. Wszolek, Z.K. Berciano, J. Schapira, A.H. O'Sullivan, S.S. Lynch, T. Bhatia, K.P. Gasser, T. Lees, A.J. Wood, N.W. Bonifati, V. Durr, A. Bressman, S. Brice, A. Aasly, J. Zabetian, C.P. Goldwurm, S. |
2008-07-01
|